MEDIASTINAL SEMINOMA
Tracking # 20-1057910
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
MEDIASTINAL SEMINOMA IS A MALIGNANT GERM CELL TUMOR IN THE MEDIASTINUM. THE TUMOR USUALLY OCCURS IN THE ANTERIOR-SUPERIOR MEDIASTINUM IN MALES AGED 20-40 YEARS OLD. THE FIRST-LINE TREATMENT IS WITH CISPLATIN BASED CHEMOTHERAPY. TO AVOID THE HIGH MORBIDITY AND MORTALITY ASSOCIATED WITH THIS CONDITION, IT MUST BE PROMPTLY DIAGNOSED AND TREATED BY A MULTIDISCIPLINARY TEAM CONSISTING OF MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, AND THORACIC SURGEONS. WHEN TREATMENT IS STARTED EARLY SURVIVAL RATES ARE > 90% 5 YEAR SURVIVAL.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I